Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRIT Capital Partners Regulatory News (RCP)

Share Price Information for RIT Capital Partners (RCP)

Share Price is delayed by 15 minutes
Get Live Data
2,295.00    -10.00 (-0.43%)
Bid:
2,295.00
Ask:
2,300.00
Spread: 5.00 (0.218%)
Market Cap: £3.11b
RCP Live PriceLast checked at - London Stock Exchange

Intraday RIT Capital Partners Share Chart

Net Asset Value(s)

17 May 2023 07:00

RNS Number : 6319Z
RIT Capital Partners PLC
17 May 2023
 

RIT CAPITAL PARTNERS PLC (LEI: P31Q1NLTW35JJGHA4667)

17 May 2023

 

Net Asset Value

 

The unaudited diluted net asset value (NAV) of RIT Capital Partners plc as at 30 April 2023 (with debt at fair value) was 2,367p per £1 ordinary share (31 March 2023: 2,405p). This is after deduction of the first interim dividend of 19p per £1 ordinary share paid on 28 April 2023.

 

April 2023 Highlights

 

Global equity markets were broadly stable in April as Q1 economic indicators and quarterly earnings remained healthy, while overall sentiment was impacted by the prospects for further rate rises and continued concerns around banking system stability. Against this backdrop, we continued to maintain a cautious net quoted equity exposure of around 37%, at the low end of our historical range.

 

· The Quoted Equities book saw healthy performance from Japan and Healthcare, partly offset by weakness in China.

· In our Private Investments book, ~12% of our private funds have reported valuations to 31 March and ~86% are held at 31 December valuations. Our second largest direct private holding, Webull, completed an equity issuance in April at a price above carrying value.

· Our Uncorrelated Strategies showed healthy performance, helped by positive contributions from market neutral strategies and continued momentum in gold.

· The key headwind during the period was currency movements, with Sterling recording gains against major currencies including the Dollar, the Euro and the Yen.

· Our share price benefitted from a narrowing of the discount, with the shares closing the month at a discount to NAV of -15.3%. The Board continued to take advantage of the discount, buying back 1.1 million shares in April. This directly benefits shareholders through the accretive impact to NAV per share.

· The portfolio continues to hold a substantial liquidity balance. As at 30 April, total cash and short-term gilts were approximately £358 million.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVQQLFFXELXBBE
Date   Source Headline
17th Aug 20225:29 pmRNSDirector/PDMR Shareholding
12th Aug 20227:00 amRNSNet Asset Value(s)
11th Aug 20229:45 amRNSBoard Appointments
2nd Aug 20227:00 amRNSHalf-year Report
20th Jul 20227:00 amRNSNet Asset Value(s)
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20227:00 amRNSTransaction in Own Shares
16th Jun 20227:00 amRNSNet Asset Value(s)
17th May 20227:00 amRNSNet Asset Value(s)
4th May 20224:51 pmRNSResult of AGM
27th Apr 20222:24 pmRNSDirector/PDMR Shareholding
26th Apr 20224:40 pmRNSBoard Appointment
19th Apr 20227:00 amRNSNet Asset Value(s)
14th Mar 20227:00 amRNSNet Asset Value(s)
1st Mar 20227:00 amRNSAnnual Financial Report
23rd Feb 20224:18 pmRNSHolding(s) in Company
22nd Feb 20222:45 pmRNSHolding(s) in Company
17th Feb 20227:00 amRNSNet Asset Value(s)
15th Feb 20224:26 pmRNSHolding(s) in Company
28th Jan 20227:00 amRNSNet Asset Value(s)
15th Dec 20217:00 amRNSNet Asset Value(s)
3rd Dec 20217:00 amRNSDirector Declaration
23rd Nov 20215:22 pmRNSDirector/PDMR Shareholding
15th Nov 20217:00 amRNSNet Asset Value(s)
4th Nov 20214:57 pmRNSBoard Announcements
15th Oct 20217:00 amRNSNet Asset Value(s)
15th Sep 20217:00 amRNSNet Asset Value(s)
16th Aug 20217:00 amRNSNet Asset Value(s)
2nd Aug 20217:00 amRNSHalf-year Report
20th Jul 20217:00 amRNSNet Asset Value(s)
28th Jun 20216:17 pmRNSDirector/PDMR Shareholding
28th Jun 20217:00 amRNSTransaction in Own Shares
22nd Jun 20217:00 amRNSTransaction in Own Shares
15th Jun 20217:00 amRNSNet Asset Value(s)
21st May 20215:15 pmRNSDirector/PDMR Shareholding
18th May 20217:00 amRNSNet Asset Value(s)
22nd Apr 20215:52 pmRNSResult of AGM
19th Apr 20217:00 amRNSNet Asset Value(s)
13th Apr 20214:17 pmRNSHolding(s) in Company
1st Apr 20217:00 amRNSDirector/PDMR Shareholding
24th Mar 20216:17 pmRNSDirector/PDMR Shareholding
16th Mar 20217:00 amRNSTransaction in Own Shares
12th Mar 20217:00 amRNSNet Asset Value(s)
11th Mar 20217:00 amRNSHolding(s) in Company
5th Mar 20219:38 amRNSDirector/PDMR Shareholding
2nd Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20218:10 amRNSHolding(s) in Company
17th Feb 20217:00 amRNSHolding(s) in Company
15th Feb 20217:00 amRNSNet Asset Value(s)
4th Feb 20217:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.